Laser-based vaccine adjuvants
AssigneeAlternative Innovative Technologies LLC
InventorsSergey B. Onikienko, Alexander V. Zemlyanoi, Boris A. Margulis, Irina V. Guzhova, Anna A. Pimenova
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlternative Innovative Technologies LLC
InventorsSergey B. Onikienko, Alexander V. Zemlyanoi, Boris A. Margulis, Irina V. Guzhova, Anna A. Pimenova
Estimating the term…
The invention is directed to a vaccine for generating an enhanced immune response in a subject previously exposed to non-destructive laser radiation, as compared to an immune response in a subject previously non-exposed to non-destructive laser radiation. The invention is also directed to use of a composition comprising a vaccine for use in combination with non-destructive laser radiation for generating an enhanced immune response from a subject, as compared to an immune response without the use of laser radiation. The laser exposure acts as an adjuvant for the vaccine, increasing the efficacy and/or potency of the vaccine.
A method of generating an enhanced immune response in a subject comprising administering a vaccine composition to a subject via intradermal, subcutaneous, and intramuscular injection in combination with non-destructive laser radiation, wherein the laser radiation is administered to the subject within an hour of the vaccine administration to the subject, thereby generating an enhanced immune response from a subject, as compared to an immune response without the use of laser radiation, wherein the vaccine composition further comprises HSP 70.
Dependencies are inferred from the claim text.